BioSpace

As biologics, biosimilars and GLP-1s drive demand for sterile drug products, CMOs and CDMOs are investing in fill-finish, lyophilization, inspection and packaging capacity to keep pace with a dynamic injectable market.

Weight loss giant Eli Lilly has penned a DNA editing deal with Profluent Bio, continuing its dealmaking spree as well as its commitment to artificial intelligence.

The FDA has renewed calls for Amgen's Tavneos to be pulled from the market, saying it has discovered new evidence that study personnel doctored the results of the drug's pivotal study in order to make it look effective.

In a Cabinet meeting, Health Secretary Robert F. Kennedy Jr. said the website could go live

Growing opposition to vaccines in the U.S., driven by recent government policy changes, makes it difficult to see a return on investment in vaccine development, Moderna CEO Stéphane Bancel said this week.

In Phase III studies, Tonmya showed significantly superior analgesic effects in patients with fibromyalgia versus placebo. The sublingual pill also led to better clinical outcomes.

"BioSpace was founded 30 years ago with a mission to champion the life sciences industry, and that commitment has never wavered," said Joshua Goodwin, CEO of BioSpace. BioSpace was founded in 1985 by Jennifer King to serve as a directory of biotech organi

A day after the regulator denied approval of Lykos' MDMA-assisted PTSD therapy, a medical journal pulled three studies related to the use of the psychedelic in the indication.